Heterocyclic compounds as adenosine receptor antagonist

US8252797B2 · kind B2 · utility

Assignee

• Advinus Therapeutics Limited

Inventors

• Venkata P. Palle · Mountain View, US
• Sujay Basu · Mumbai, IN
• Yogesh Waman · Pune, IN
• Vidya Ramdas · Pune, IN
• Dinesh Barawkar · Lake Forest, US
• Meena Patel · Libertyville, US
• Anil Panmand · Pimpri-Chinchwad, IN

Key dates

• Filing date: Mar 26, 2009
• Grant date: Aug 28, 2012
• Expiry date: Feb 7, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D473/08
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of the present disclosure are fused pyrimidine compounds of formula (I), its tautomers, polymorphs, stereoisomers, prodrugs, solvate or a pharmaceutically acceptable salts thereof, as Adenosine receptor antagonists.Processes of their preparation are also described in the disclosure.